Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
$AU AngloGold Ashanti just crossed a significant milestone. The stock recently traded at $36.50, pushing above the average analyst 12-month target price of $36.00. This move signals increasing investor confidence and could prompt analysts to revisit their projections. When a stock surpasses its target, it often reflects stronger-than-expected performance or a shifting market sentiment in favor of the company.
$CAVA CAVA Group caught the attention of JP Morgan, which upgraded the stock from "Neutral" to "Overweight." This bullish shift suggests JP Morgan sees substantial upside potential. The upgrade may reflect confidence in CAVA’s growth trajectory and improving financial performance, positioning the stock as a stronger buy for investors seeking exposure to the fast-casual dining sector.
$COE 51Talk Online Education Group released its fourth-quarter and full-year 2024 financial results. The report highlighted gross billings and net revenue figures alongside active student growth. The company's ability to sustain and grow its user base amid evolving educational trends remains a crucial factor for future valuation. Investors are watching closely for how these numbers will shape analyst sentiment moving forward.
$DHR Goldman Sachs has upgraded Danaher Corporation seeing a 20% upside potential. With shares now trading at more attractive valuations, Goldman’s vote of confidence reflects optimism about the conglomerate’s long-term growth prospects. This upgrade could bring renewed investor interest as the company works to strengthen its market position across various sectors.
$FCX JP Morgan has turned bullish on Freeport-McMoRan upgrading the stock from "Neutral" to "Overweight." This move reflects increased confidence in the copper and gold producer's outlook. With demand for industrial metals remaining robust, the upgrade signals a belief that Freeport-McMoRan is well-positioned to capitalize on market trends and deliver shareholder value.
$HUBS Bernstein initiated coverage of HubSpot with a "Market Perform" recommendation. This neutral stance suggests that while HubSpot remains a significant player in customer relationship management software, Bernstein sees limited near-term catalysts for substantial upside. Investors will likely focus on the company’s ability to maintain growth in a competitive tech environment.
$KKR Wells Fargo upgraded KKR from "Equal-Weight" to "Overweight," highlighting stronger growth prospects for the global investment firm. The upgrade reflects growing optimism about KKR’s ability to deliver solid returns and navigate the evolving financial landscape. This move suggests the firm’s diverse portfolio and capital management strategy could drive continued performance.
$LUV Southwest Airlines received two upgrades. Melius Research lifted its rating from "Sell" to "Hold," while UBS moved the stock from "Sell" to "Neutral." These upgrades come as the airline works through industry headwinds and seeks to stabilize operations. Improved market conditions or cost management may be driving the more favorable outlooks from both firms.
$NVS Novartis AG crossed above the average analyst 12-month target price of $113.00, recently trading at $113.21. This move suggests that investor sentiment is outpacing analyst projections, potentially leading to a reassessment of the pharmaceutical giant’s growth potential. Surpassing the target price often reflects underlying business strength or improved market positioning.
$SAM Citigroup upgraded Boston Beer from "Neutral" to "Buy," signaling increased confidence in the company’s growth trajectory. This bullish call reflects optimism around product innovation and consumer demand. With the upgrade, Citigroup suggests that Boston Beer may be poised for stronger performance despite competitive pressures in the beverage market.
$SMCI JP Morgan upgraded Super Micro Computer from "Underweight" to "Neutral," citing the ramp-up of Nvidia’s Blackwell chip as a key catalyst. Analyst Samik Chatterjee also raised the price target by $10 to $45. The upgrade indicates improving sentiment as uncertainty around regulatory filings eases, positioning Super Micro to benefit from increasing demand for advanced computing solutions.
$VCYT Craig-Hallum initiated coverage of Veracyte with a "Buy" recommendation. This positive outlook reflects confidence in Veracyte’s innovative diagnostic solutions and their growth potential. The initiation suggests the firm sees compelling upside opportunities as Veracyte expands its market presence and advances its product pipeline.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.